Prevent Mix-Ups With Testosterone Products
New safety data for testosterone replacement therapy might lead to more Rxs...and chances for mishaps.
Currently, testosterone product labels caution about a possible increased risk of heart attack and stroke.
Now a study suggests using transdermal 1.62% testosterone gel (AndroGel) daily for about 22 months does not increase risk of cardiovascular death, heart attack, or stroke more than placebo.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote